• FirefoxInstall the new Firefox »
  •  Dow Down0.47% Nasdaq Down0.56%

    Luminex Corporation (LMNX)

    -NasdaqGS
    15.64 Down 0.45(2.80%) Mar 3, 4:00PM EST
    Add to Portfolio
    ProfileGet Profile for:
    Luminex Corporation
    12212 Technology Boulevard
    Austin, TX 78727
    United States - Map
    Phone: 512-219-8020
    Fax: 512-219-5195
    Website: http://www.luminexcorp.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Medical Instruments & Supplies
    Full Time Employees:745

    Business Summary 

    Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics and life sciences industries worldwide. It offers xMAP technology, an open architecture, multiplexing technology that allows simultaneous analysis of approximately 500 bioassays from a drop of fluid by reading biological tests on the surface of microscopic polystyrene beads called microspheres; and MultiCode technology used for real-time polymerase chain reaction (PCR) and multiplexed PCR assays. The company’s products include Luminex LX 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; and MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids. It also offers MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite to simplify laboratory workflow and enhance productivity; respiratory viral family of products, including respiratory viral panel to identify the causative agent for respiratory infections; and gastrointestinal pathogen panel family of products, such as in vitro diagnostic (IVD) assays to identify the pathogens causing infectious gastroenteritis. In addition, the company offers MultiCode assays and products comprising HSV1/2 kits, analyte specific reagents, and other products to detect infectious agents in clinical samples; cystic fibrosis family of products comprising IVD kits for cystic fibrosis genotyping; personalized medicine family of products consisting of assays to determine the drug metabolism status; and specialty product family and instrumentation products, as well as operates an original equipment manufacturer of custom reagents and instrumentation. It serves pharmaceutical companies, clinical laboratories, and research and medical institutions. Luminex Corporation was founded in 1995 and is headquartered in Austin, Texas.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Luminex Corporation

    Corporate Governance 
    Luminex Corporation’s ISS Governance QuickScore as of Feb 1, 2015 is 9. The pillar scores are Audit: 2; Board: 9; Shareholder Rights: 8; Compensation: 9.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
     PayExercised
    Mr. Harriss T. Currie , 53
    Chief Financial Officer, Principal Accounting Officer, Sr. VP of Fin. and Treasurer
    455.00K969.00K
    Dr. Jeremy Bridge-Cook Ph.D., 46
    Sr. VP of R&D
    446.00K0.00
    Mr. David S. Reiter , 48
    Sr. VP, Gen. Counsel and Corp. Sec.
    409.00K336.00K
    Mr. Russell W. Bradley , 51
    Chief Marketing & Sales Officer and Sr. VP of Corp. Devel.
    405.00K0.00
    Mr. Patrick J. Balthrop Sr., 58
    Consultant
    1.04M2.50M
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders